Suchergebnisse - "Cheng Li"

PubPharm (121)

1

Performance of ChatGPT on Chinese Master's Degree Entrance Examination in Clinical Medicine.

in: PLoS ONE | 2024

von Ke-Cheng Li | Zhi-Jun Bu | Md Shahjalal | +6

2

p21CIP/WAF1 saRNA inhibits proliferative vitreoretinopathy in a rabbit model.

in: PLoS ONE | 2023

von Qi Zhang | Yangchen Guo | Moorim Kang | +5

3

p21CIP/WAF1 saRNA inhibits proliferative vitreoretinopathy in a rabbit model

in: PLoS ONE | 2023

von Qi Zhang | Yangchen Guo | Moorim Kang | +5

4

Single-Atom Ce-N4-C-(OH)2 Nanozyme-Catalyzed Cascade Reaction to Alleviate Hyperglycemia

in: Research | 2023

von Guangchun Song | Jia Xu | Hong Zhong | +9

5

Deciphering complex breakage-fusion-bridge genome rearrangements with Ambigram

in: Nature Communications | 2023

von Chaohui Li | Lingxi Chen | Guangze Pan | +2

6

Enhanced Chemo‐Immunotherapy Strategy Utilizing Injectable Thermosensitive Hydrogel for The Treatment of Diffuse Peritoneal Metastasis in Advanced Colorectal Cancer

in: Advanced Science | 2023

von Meng Wang | DanRong Hu | Yun Yang | +10

7

Hypothyroidism and related comorbidities on the risks of developing tinnitus

in: Scientific Reports | 2022

von Alan Hsu | Yung-an Tsou | Tang-Chuan Wang | +3

8

Aspalathus linearis suppresses cell survival and proliferation of enzalutamide-resistant prostate cancer cells via inhibition of c-Myc and stability of androgen receptor.

in: PLoS ONE | 2022

von Bi-Juan Wang | Shih-Han Huang | Cheng-Li Kao | +10

9

Multiomics Analysis Identifies SOCS1 as Restraining T Cell Activation and Preventing Graft‐Versus‐Host Disease

in: Advanced Science | 2022

von Huidong Guo | Ruifeng Li | Ming Wang | +10

10

Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3Kα/β/δ treatment

in: Nature Communications | 2022

von Zhi Qi | Zihan Xu | Liuzhen Zhang | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]